赫兹水对不同类型认知功能障碍患者的疗效及预后的应用研究

Application of Hertzian Water to the Therapeutic Effect and Prognosis of Patients with Different Types of Cognitive Dysfunction

摘要: 目的：本研究通过案例报道赫兹水在脑梗、帕金森病及阿尔茨海默病所致认知功能障碍治疗中的应用案例及效果观察，为相关疾病治疗提供科学参考。方法：回顾性整理了接受过赫兹水干预 + 综合康复的脑梗、帕金森病、阿尔茨海默病伴认知障碍的患者临床资料，通过专业认知功能评估量表评估认知功能变化，检测血清超氧化物歧化酶活性反映抗氧化能力，测定外周血淋巴细胞微核率体现抗辐射水平，对比分析赫兹水干预前后各项指标差异及患者临床症状改善情况。结果：阿尔茨海默病患者接受赫兹水治疗后，3个月内认知功能也得到一定程度提升，6个月能够自行穿衣、洗漱等简单活动，情绪稳定；脑梗偏瘫患者在3个月内下肢功能恢复，6个月上肢功能明显改善，1年内恢复社交；帕金森病患者饮用赫兹水1个月内震颤症状即见减轻，3个月内震颤明显控制，言语增多，情绪平稳，6个月生活自理能力提高。在检测指标方面，患者接受赫兹水干预后，血清超氧化物歧化酶活性均升高，外周血淋巴细胞微核率下降，且随访期间未见并发症或不良反应发生。结论：赫兹水在这些临床案例中展现出对脑梗、帕金森病及阿尔茨海默病认知及运动功能障碍治疗的积极作用，在改善认知功能方面有一定成效且安全性较高，为临床治疗提供了有价值的线索与实践经验。

Abstract: Objective: This study reported the application cases and effect observation of Hertzian water in the treatment of cognitive dysfunction caused by cerebral infarction, Parkinson’s disease and Alzheimer’s disease, and provided scientific reference for the treatment of related diseases. Methods: The clinical data of patients with cerebral infarction, Parkinson’s disease and Alzheimer’s disease with cognitive impairment who have received Hertzian water intervention + comprehensive rehabilitation were retrospectively collated, the changes in cognitive function were evaluated by the professional cognitive function assessment scale, the serum superoxide dismutase activity was detected to reflect the antioxidant capacity, the micronucleus rate of peripheral blood lymphocytes was measured to reflect the radiation resistance level, the differences of various indicators and the improvement of patients’ clinical symptoms before and after Hertzian water intervention were compared and analyzed. Results: After receiving Hertzian water treatment, Alzheimer’s patient also improved her cognitive function to some extent within 3 months, and was able to dress and wash on their own, and be emotionally stable within 6 months. The patient with cerebral infarction hemiplegia recovered their lower limb function in 3 months, and improved their upper limb function significantly in 6 months, and resumed social interaction within 1 year. The patient with Parkinson’s disease can see a reduction in tremor symptoms after drinking Hertzian water for 1 month, significantly controlled tremor within 3 months, increased speech, stable mood, and improved selfcare ability in 6 months. In terms of detection indicators, serum superoxide dismutase activity increased, peripheral blood lymphocyte micronucleus rate decreased, and no complications or adverse reactions occurred during the follow-up period. Conclusion: In these clinical cases, Hertzian water has shown positive effects on the treatment of cognitive and motor dysfunction in cerebral infarction, Parkinson’s disease and Alzheimer’s disease, and has certain effectiveness and high safety in improving cognitive function, providing valuable clues and practical experience for clinical treatment.